Allogene Therapeutics Inc (ALLO.OQ)
ALLO.OQ on NASDAQ Stock Exchange Global Select Market
Change (% chg)
Allogene Therapeutics, Inc. is a clinical stage immuno-oncology company. The Company is focused on developing and commercializing of allogeneic T cell therapies for the treatment of cancer. It is involved in developing a pipeline of multiple allogeneic chimeric antigen receptor (CAR) T cell product candidates utilizing protein... (more)
No Ratios Available.